Eurofins Genomics launches EXTREmers
Eurofins Genomics has launched its EXTREmer oligonucleotides in the US – adding another ‘tool’ to help researchers advance drug discovery.
Archives for December 14, 2016
update
Sugar lumps? Excipient impurities may be risk to patients says researcher
Newly identified impurities in sugar excipients pose a risk to patients and could explain why some drugs fail safety tests according to scientists from the Netherlands.
BMS reshuffles US operations with multiple R&D closures and construction
Bristol-Myers Squibb has announced plans to pull the plug on some US facilities and streamline construction and investment around “vibrant academic ecosystems”.
Sartorius to expand recently acquired cell line business, Cellca
Sartorius Stedim Cellca has said it will build a laboratory at newly acquired site in Ulm, Germany and hire additional staff.